BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15607795)

  • 1. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
    DeMarco RA; Fink MP; Lotze MT
    Mol Immunol; 2005 Feb; 42(4):433-44. PubMed ID: 15607795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogen-induced private conversations between natural killer and dendritic cells.
    Della Chiesa M; Sivori S; Castriconi R; Marcenaro E; Moretta A
    Trends Microbiol; 2005 Mar; 13(3):128-36. PubMed ID: 15737731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
    Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
    AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.
    Erlandsson Harris H; Andersson U
    Eur J Immunol; 2004 Jun; 34(6):1503-12. PubMed ID: 15162419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells.
    Dumitriu IE; Baruah P; Bianchi ME; Manfredi AA; Rovere-Querini P
    Eur J Immunol; 2005 Jul; 35(7):2184-90. PubMed ID: 15915542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB1 loves company.
    Bianchi ME
    J Leukoc Biol; 2009 Sep; 86(3):573-6. PubMed ID: 19414536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
    Hreggvidsdottir HS; Ostberg T; Wähämaa H; Schierbeck H; Aveberger AC; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
    J Leukoc Biol; 2009 Sep; 86(3):655-62. PubMed ID: 19564572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.
    Bianchi ME; Manfredi AA
    Immunol Rev; 2007 Dec; 220():35-46. PubMed ID: 17979838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo.
    Rotta G; Edwards EW; Sangaletti S; Bennett C; Ronzoni S; Colombo MP; Steinman RM; Randolph GJ; Rescigno M
    J Exp Med; 2003 Oct; 198(8):1253-63. PubMed ID: 14568983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is HMGB1 an osteocyte alarmin?
    Bidwell JP; Yang J; Robling AG
    J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of HMGB1/RAGE in inflammatory cardiomyopathy.
    Volz HC; Kaya Z; Katus HA; Andrassy M
    Semin Thromb Hemost; 2010 Mar; 36(2):185-94. PubMed ID: 20414834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA.
    Berger M; Ablasser A; Kim S; Bekeredjian-Ding I; Giese T; Endres S; Hornung V; Hartmann G
    J Immunother; 2009 Apr; 32(3):262-71. PubMed ID: 19242374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dealing with death: HMGB1 as a novel target for cancer therapy.
    Lotze MT; DeMarco RA
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1405-9. PubMed ID: 14763124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 preconditioning: therapeutic application for a danger signal?
    Klune JR; Billiar TR; Tsung A
    J Leukoc Biol; 2008 Mar; 83(3):558-63. PubMed ID: 17938274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dialogue between human natural killer cells and dendritic cells.
    Moretta A
    Curr Opin Immunol; 2005 Jun; 17(3):306-11. PubMed ID: 15886122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells.
    Poupot M; Fournié JJ; Poupot R
    J Leukoc Biol; 2008 Nov; 84(5):1298-305. PubMed ID: 18687904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.
    Vanhoutte F; Paget C; Breuilh L; Fontaine J; Vendeville C; Goriely S; Ryffel B; Faveeuw C; Trottein F
    Immunol Lett; 2008 Feb; 116(1):86-94. PubMed ID: 18166232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.